Taking action to address Europe’s non-communicable disease epidemic
Stefan Woxström at AstraZeneca considers the high rates of non-communicable diseases and how governments and healthcare systems can improve their treatments
1 October 2023Stefan Woxström at AstraZeneca considers the high rates of non-communicable diseases and how governments and healthcare systems can improve their treatments
1 October 2023Tina Backhouse from Theramex considers the issues with the current standard of women’s healthcare in the UK, and what steps need to be taken to improve this
1 October 2023Alicia Staley from Medidata explores the need for diversity in clinical trials, especially in terms of gender diversity, and how this can improve outcomes of clinical trials
1 October 2023Vicky Qu at BioMap considers the use of artificial intelligence in immuno-oncology and how its use can improve conventional drug discover y processes
1 October 2023Lukasz Jaremko from King Abdullah University of Science and Technology, Saudi Arabia explains how using nuclear magnetic resonance to study the dynamics of epigenetic targets may enable drug development that does not kill but resets cancer cells to a benign state
1 October 2023Amy McKee from Parexel considers the need for diversity in oncology clinical trials in order to fully realise the potential of personalised medicine
1 October 2023Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases
Rare Diseases, 1 December 2022Pharmafile speaks to Chiesi Group: Chiesi Group tells Pharmafile about the challenges facing rare disease research and their hopes for the future of this area
Rare Diseases, 1 December 2022Patient advocacy organisations can form an effective partnership between clinical trials and patients for more efficient trials
Rare Diseases, 1 December 2022The rare disease treatment market has been rapidly changing and receive deserved recognition
Rare Diseases, 1 December 2022Takeda tells Pharmafile about the role of combination treatments in rare diseases, and strategies to make them more accessible
Rare Diseases, 31 May 2022Many advancements have been made within the rare disease field, including gene editing and viral delivery strategies
Rare Diseases, 31 May 2022Vicky Qu at BioMap considers the use of artificial intelligence in immuno-oncology and how its use can improve conventional drug discover y processes
Oncology, 1 October 2023Lukasz Jaremko from King Abdullah University of Science and Technology, Saudi Arabia explains how using nuclear magnetic resonance to study the dynamics of epigenetic targets may enable drug development that does not kill but resets cancer cells to a benign state
Oncology, 1 October 2023Amy McKee from Parexel considers the need for diversity in oncology clinical trials in order to fully realise the potential of personalised medicine
Oncology, 1 October 2023Dr Mitchell Smith and Dr Julie Dodds tell Pharmafile about recent R&D in the field of blood cancers including follicular lymphoma
Oncology, 1 October 2023Professor Hendrik van Poppel talks to Pharmafile about new campaigns to improve prostate cancer screening, the current standard-of-care treatments and what obstacles still need to be addressed in treatment
Oncology, 1 October 2023Pharmafilespeaks to Allergy UK: Allergy UK explores the future of eczema diagnosis, treatment, and support
Dermatology, 1 December 2021Organon discusses the ways in which women's skin conditions can be managed
Dermatology, 1 December 2021FIDE discuss the need for communication between patients and their HCPs, specifically with virtual platforms in mind, and how this can improve dermatology care
Dermatology, 1 December 2021There have been significant advances in dermatological care, this article explores this as well as looking forward to what still needs to be done
Dermatology, 1 December 2021The COVID-19 pandemic has been challenging service-wide for the NHS, but the pharma industry can support patients and the NHS going forward
Dermatology, 1 December 2021Pharmafile speaks to Sapphire Clinics: Sapphire Clinics discuss the benefits of medical cannabis for pain management and how this has changed in the last decade
31 May 2022Pharmafile speaks to Futura for their insights into the effective delivery of drugs for pain management and alternative technologies
31 May 2022Pain management is key for both patient and HCP, but how can compounding medication aid in treatment?
31 May 2022